New hope for tough leukemia? tiny trial tests targeted pill
Disease control
Recruiting now
This study tests an oral drug called olutasidenib in 3 Japanese patients whose acute myeloid leukemia (AML) has a specific IDH1 gene mutation and has not responded to or returned after other treatments. The main goal is to check safety, but researchers will also see if the drug c…
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC